Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Quattropani

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2003
Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptorRocco Cirillo, Enrico Gillio Tos, Matthias K Schwarz, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Discovery of a novel series of potent S1P1 agonistsStefano Crosignani, Agnes Bombrun, David Covini, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic AcidsStefano Crosignani, Catherine Jorand-Lebrun, Gordon Campbell, et al.
Chemmedchem|March 5, 2015
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacyAnna Quattropani, Wolfgang H B Sauer, Stefano Crosignani, et al.
Journal of Medicinal Chemistry|November 24, 2005
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonistsAnna Quattropani, Jérôme Dorbais, David Covini, et al.
Cell Chemical Biology|March 28, 2026
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteinsCamilla Gustafsen, Joachim Vilstrup, Marianne Kristensen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|March 28, 2003
Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptorRocco Cirillo, Enrico Gillio Tos, Matthias K Schwarz, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Discovery of a novel series of potent S1P1 agonistsStefano Crosignani, Agnes Bombrun, David Covini, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic AcidsStefano Crosignani, Catherine Jorand-Lebrun, Gordon Campbell, et al.
Chemmedchem|March 5, 2015
Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacyAnna Quattropani, Wolfgang H B Sauer, Stefano Crosignani, et al.
Journal of Medicinal Chemistry|November 24, 2005
Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonistsAnna Quattropani, Jérôme Dorbais, David Covini, et al.
Cell Chemical Biology|March 28, 2026
Reshaping the progranulin/sortilin interaction for targeted degradation of extracellular proteinsCamilla Gustafsen, Joachim Vilstrup, Marianne Kristensen, et al.
Pageof 2